NEU3 inhibits the endocytosis of β1 integrin in RCC, promotes integrin recycling, increases integrin levels in the cell plasma membrane, and activates the EGFR and FAK/Akt EGFR and FAK/Akt signaling pathways [94]. Here, PTK2 is linked to renal cell carcinoma.